Details

Autor(en) / Beteiligte

• Engels, Eric A.
• Yanik, Elizabeth L.
• Wheeler, Willian
• Gill, M. John
• Sheils, Meredith S.
• Dubrow, Robert
• Althoff, Keri N.
• Silverberg, Michael J.
• Brooks, John T.
• Kitahata, Mari M.
• Goedert, James J.
• Grover, Surbhi
• Mayor, Angel M.
• Moore, Richard D.
• Park, Lesley S.
• Rachlis, Anita
• Sigel, Keith
• Sterling, Timothy R.
• Thorne, Jennifer E.
• Pfeiffer, Ruth M.

Titel

Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America

Ist Teil von

• Clinical infectious diseases, 2017-08, Vol.65 (4), p.636-643

Ort / Verlag

United States: Oxford University Press

Erscheinungsjahr

2017

Link zum Volltext

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• Background. Cancer remains an important cause of morbidity and mortality in people with human immunodeficiency virus (PWHIV) on effective antiretroviral therapy (ART). Estimates of cancer-attributable mortality can inform public health efforts. Methods. We evaluated 46 956 PWHIV receiving ART in North America HIV cohorts (1995–2009). Using information on incident cancers and deaths, we calculated population-attributable fractions (PAFs), estimating the proportion of deaths due to cancer. Calculations were based on proportional hazards models adjusted for age, sex, race, HIV risk group, calender year, cohort, CD4 count, and viral load. Results. There were 1997 incident cancers and 8956 deaths 267 145 person-years of follow-up, and 11.9% of decedents had a prior cancer. An estimated 9.8% of deaths were attributable to cancer (cancer-attributable mortality rate 327 per 100 000 person-years). PAFs were 2.6% for AIDS-defining cancers (ADCs, including non-Hodgkin lymphoma, 2.0% of deaths) and 7.1% for non-AIDS–defining cancers (NADCs: lung cancer, 2.3%; liver cancer, 0.9%). PAFs for NADCs were higher in males and increased strongly with age, reaching 12.5% in PWHIV aged 55+ years. Mortality rates attributable to ADCs and NADCs were highest for PWHIV with CD4 counts <100 cells/mm3. PAFs for NADCs increased during 1995–2009, reaching 10.1% in 2006–2009. Conclusions. Appromimately 10% of deaths in PWHIV prescribed ART during 1995–2009 were attributable to cancer, but this fraction increased over time. A large proportion of cancer-attributable deaths were associated with non-Hodgkin lymphoma, lung cancer, and liver cancer. Deaths due to NADCs will likely grow in importance as AIDS mortality declines and PWHIV age.